ArticleIranian journal of pharmaceutical research : IJPR
Evaluating the Effects of
Article in Iranian journal of pharmaceutical research : IJPR. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Chronic fatigue syndrome (CFS) is a complex and debilitating disorder characterized by extreme fatigue that cannot be explained by any underlying medical condition. Chronic fatigue syndrome significantly impacts the daily lives of patients with chronic obstructive pulmonary disease (COPD). Currently, there is no definitive treatment for CFS. Objectives: This study aimed to determine the effects of Methods: This study was conducted as a randomized, double-blind, placebo-controlled clinical trial. Chronic obstructive pulmonary disease patients with CFS were randomly assigned to either the intervention or control group using block randomization generated by the Sealed Envelope online tool. Data were coded to ensure that both researchers and analysts were blinded to group assignments. Participants in the intervention group (n = 37) received 30 mg of dry saffron extract capsules twice daily for eight weeks, while those in the control group (n = 34) received a placebo. The primary outcome was the effect of Results: Based on mixed repeated measures ANOVA models, the effect of Conclusions: The findings indicate that
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.